The Haitian Government included a budget line of $900,000 in its operating budget in response to HIV-related U.S. aid cuts and freezes to purchase and manage HIV medicines. At this time, Haiti only had six months of stocked HIV medicine left.
Date: 3/25
Region: Latin America & Caribbean
Country: Haiti
Topic: Health
Policy Lens: Global Health Security
Entry Type: Secondary Effect
Additional Context: Information provided by UNAIDS, updated as of May 2025, highlights a broader regional trend of affected countries seeking supplementary domestic budget allocations to cover antiretroviral, or ARV, procurement and supply chain costs, with some confirmed and others still under negotiation.
Devex Researcher Note: As of December 2024, 85% of people living with HIV had access to antiretroviral therapy in Haiti. Because of the cuts, access to adequate HIV care for 35,000 patients will be impacted. The Transitional Presidential Council of Haiti has promised that “there will never be a shortage of [ARV] stock in the country.” There is no available data to confirm this claim. Against a backdrop of natural disasters, collapsing state institutions, and escalating gang violence, in February 2026, the World Health Organization warned that Haiti's health system is “near collapse."
Source: UNAIDS